Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
11.38
-0.19 (-1.64%)
At close: Mar 4, 2026, 4:00 PM EST
11.50
+0.12 (1.06%)
After-hours: Mar 4, 2026, 5:59 PM EST
Beta Bionics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Beta Bionics stock have an average target of 26.73, with a low estimate of 14 and a high estimate of 40. The average target predicts an increase of 134.89% from the current stock price of 11.38.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Beta Bionics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 7 | 7 | 7 | 7 | 6 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +93.32% | Feb 18, 2026 |
| Baird | Baird | Hold Maintains $28 → $14 | Hold | Maintains | $28 → $14 | +23.02% | Feb 18, 2026 |
| Stifel | Stifel | Strong Buy Maintains $31 → $25 | Strong Buy | Maintains | $31 → $25 | +119.68% | Feb 4, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $37 → $25 | Strong Buy | Maintains | $37 → $25 | +119.68% | Feb 2, 2026 |
| TD Cowen | TD Cowen | Hold Initiates $17 | Hold | Initiates | $17 | +49.38% | Jan 27, 2026 |
Financial Forecast
Revenue This Year
135.37M
from 100.25M
Increased by 35.03%
Revenue Next Year
180.37M
from 135.37M
Increased by 33.24%
EPS This Year
-1.81
from -1.81
EPS Next Year
-1.82
from -1.81
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 151.2M | 210.6M | |||
| Avg | 135.4M | 180.4M | |||
| Low | 121.3M | 148.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 50.8% | 55.6% | |||
| Avg | 35.0% | 33.2% | |||
| Low | 21.0% | 9.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.33 | -0.92 | |||
| Avg | -1.81 | -1.82 | |||
| Low | -2.28 | -2.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.